Welcome to the Investor Relations section of CareFusion’s website. Here, we provide access to a variety of shareholder materials, including financial and stock information, corporate governance resources and access to our presentations and events. We are committed to providing you with convenient access to these resources, and if you need additional information, please contact us.
You can also sign up to receive email alerts when new company information is available by going to CareFusion’s Email Alerts page.
To receive printed copies of CareFusion investor materials by mail, you can submit an on-line request here. You may also send an email to email@example.com with your contact information and material request.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, and V. Mueller® and Snowden-Pencer® surgical instruments.
- Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment
- Diluted earnings per share (EPS) from continuing operations totaled $0.45 on a GAAP basis and remained even with prior year at $0.54 per adjusted share
- Company reaffirmed fiscal 2014 revenue and EPS guidance
SAN DIEGO, Feb. 3, 2014 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financi...
SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release second quarter fiscal 2014 results on Monday, Feb. 3, following the close of trading on the New York Stock Exchange.
The company will host a conference call on Feb. 3 at 2 p.m. PST (5 p.m. EST) to discuss the results for its second quarter fiscal 2014, ended Dec. 31, 2013. To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the call beg...
Creates An Industry Leader in Specialty Disposables
SAN DIEGO, Dec. 31, 2013 /PRNewswire/ -- CareFusion (NYSE:CFN), a leading global medical technology company, today announced the completion of its acquisition of the Vital Signs division from GE Healthcare in the U.S., China and certain other geographies.
CareFusion agreed to purchase Vital Signs for $500 million. In connection with this first closing, CareFusion paid...
CME Designs and Manufactures Compact, State of the Art Infusion Systems
SAN DIEGO, Dec. 9, 2013 /PRNewswire/ -- CareFusion (NYSE: CFN), a leading global medical technology company, today announced it will invest $100 million for a 40 percent minority stake in Caesarea Medical Electronics (CME), a global infusion pump systems manufacturer.
CME, headquartered in Israel, designs, manufactures and markets a range of infusion and syringe pumps as well as related accessories and dispo...
Cautions Concerning Forward-Looking Statements: This website contains statements that are forward-looking and consequently are subject to risks and uncertainties. Examples of these statements include statements regarding our financial guidance, our expectations regarding hospital capital spending, our expected standup costs and other costs related to the separation from Cardinal Health and other statements regarding matters that are not historical facts. You should be aware that certain factors may affect us in the future and could cause actual results to differ materially from those expressed in these forward-looking statements. Such factors include the risk factors set forth in our Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement to reflect subsequent events or circumstances.